Chemotherapy

Titlesort descending Average Rating
Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme. 50.00%
Sorafenib and radiation: A promising combination in colorectal and pancreas cancer 70.00%
Synergistic activity of PHY906 with capecitabine in pancreatic carcinoma. 80.00%
Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. 70.00%
Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growt 80.00%
Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for NSCLC. 70.00%
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Onco 40.00%
The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline 70.00%
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary stu 60.00%
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer. 50.00%
Treatment of locally advanced pancreatic cancer with concurrent uftoral and radiotherapy. Results from 64 patients treated from 80.00%
Tumoral angiogenesis: review of the literature. 50.00%
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. 80.00%
Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside. 80.00%
WITHDRAWN: Ovarian ablation for early breast cancer. 50.00%

Pages